None

Brigatinib (Brigatinib), as a targeted therapy drug designed specifically forALK-positive non-small cell lung cancer, is gradually becoming an important part of the treatment plan for many patients. However, in order to ensure that the drug can have the best effect and minimize adverse reactions, patients must understand the correct method of taking the drug and the related precautions.

Patients should strictly follow the instructions given by their doctor when taking brigatinib. Typically, the starting dose of this drug is 90 mg orally daily for 7 days. If the patient does not experience serious adverse reactions or intolerance during this period, the dose can be adjusted to 180 mg daily. It is worth noting that if the medication is suspended for more than 14 days due to reasons other than adverse reactions, it is necessary to start again from 90 mg per day when restarting. After taking it continuously for 7 days, the dose should be adjusted according to the previous tolerance. Brigatinib should be swallowed whole, without crushing or chewing, and may be taken with food or alone.

During brigatinib treatment, patients also need to pay special attention to the following aspects:

1. Handling missed doses or vomiting: If a dose is accidentally missed or vomiting occurs after taking it, the patient does not need to take a supplementary dose and only needs to continue taking it normally at the next scheduled time.

2. Beware of drug interactions: Brigatinib may interact with other drugs, thereby affecting the therapeutic effect or increasing the risk of adverse reactions. Therefore, patients should inform their doctors about all the medications they are taking during medication so that the doctor can evaluate and adjust them.

3. Monitor for adverse reactions: Brigatinib may cause a series of adverse reactions, including nausea, vomiting, diarrhea, fatigue, headache, and vision changes. Patients should pay close attention to their physical condition and contact their doctor immediately if they feel unwell and describe their symptoms in detail.

4. Regular examinations: During treatment, patients should regularly undergo liver function, kidney function, electrocardiogram and other related examinations to ensure that they are in good physical condition. At the same time, possible adverse reactions such as hyperglycemia and hypertension need to be monitored regularly and properly handled under the guidance of a doctor.

5. Strictly follow the doctor’s instructions: While taking brigatinib, patients must strictly abide by the doctor’s instructions and are not allowed to adjust the dosage or change the medication method on their own. Any questions or concerns about medication should be communicated to your doctor promptly.

6. Pay attention to storage conditions: Brigatinib should be stored at room temperature and away from moisture and high temperature environments to ensure the stability and effectiveness of the drug.

In summary, brigatinib provides an effective treatment option for patients with ALK-positive non-small cell lung cancer. However, in order to ensure treatment effectiveness and patient safety, patients must understand and follow the correct medication methods and related precautions. By working closely with doctors and strictly following medical instructions, patients can expect good results.